CIK 0001553643
- Non-accelerated filer
- Smaller reporting company
RELMADA THERAPEUTICS, INC.
Sign in to watch- Ticker
- RLMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 455401931
- Phone
- +1 646-876-3459
- Business address
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
- Former names
- CAMP NINE, INC.
- Open-market buys, last 90 days
- $1,671,990
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$1,671,990. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-12-14 | TRAVERSA SERGIO Chief Executive Officer | Purchase | +30 | $2.97 | $89 | 320,352 |
| 2015-12-14 | Shenouda Maged Director | Purchase | +2,000 | $2.89 | $6K | 2,000 |
| 2015-12-14 | CASAMENTO CHARLES J Director | Purchase | +1,700 | $2.98 | $5K | 1,700 |
| 2015-12-14 | CASAMENTO CHARLES J Director | Purchase | +1,300 | $2.97 | $4K | 3,000 |
| 2015-12-14 | CASAMENTO CHARLES J Director | Purchase | +300 | $2.90 | $870 | 3,300 |
| 2015-12-14 | CASAMENTO CHARLES J Director | Purchase | +500 | $2.95 | $1K | 3,800 |
| 2015-12-14 | CASAMENTO CHARLES J Director | Purchase | +400 | $2.98 | $1K | 4,200 |
| 2015-02-23 | TRAVERSA SERGIO Chief Executive Officer | Grant or award · Options to purchase common stock | +225,000 | $2.70 | $608K | 872,745 |
| 2015-02-23 | Salinas Eliseo Oreste President and CSO | Grant or award · Options to purchase common stock | +225,000 | $2.70 | $608K | 250,944 |
| 2015-02-23 | BECK DOUGLAS Chief Financial Officer | Grant or award · Options to purchase common stock | +25,000 | $2.70 | $68K | 104,437 |
Page 19 of 19 · 370 trades